Log in
Enquire now
‌

US Patent 12076366 Therapeutic vitamin D conjugates

Patent 12076366 was granted and assigned to Extend Biosciences on September, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Extend Biosciences
Extend Biosciences
0
Date Filed
July 3, 2020
0
Date of Patent
September 3, 2024
0
Patent Applicant
Extend Biosciences
Extend Biosciences
0
Patent Application Number
16920652
0
Patent Citations
‌
US Patent 7045318 Recombinant fusion proteins to growth hormone and serum albumin
0
‌
US Patent 7049285 Biocompatible polymers including peptide spacer
0
‌
US Patent 7057012 PTH functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules
0
‌
US Patent 7078496 Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith
0
‌
US Patent 7141547 Albumin fusion proteins comprising GLP-1 polypeptides
0
‌
US Patent 7176278 Modified transferrin fusion proteins
0
‌
US Patent 7186797 Polypeptide conjugates with extended circulating half-lives
0
‌
US Patent 7217689 Glycosylation analogs of erythropoietin
0
‌
US Patent 7244834 Nucleic acids encoding PTH functional domain conjugate peptides
0
‌
US Patent 7256253 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
0
•••
Patent Inventor Names
Howard P. Sard
0
Daniel B. Hall
0
Vishnumurthy Hegde
0
Laura M. Hales
0
Tarik Soliman
0
Christopher So
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12076366
0
Patent Primary Examiner
‌
Julie Ha
0

Find more entities like US Patent 12076366 Therapeutic vitamin D conjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.